Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IGSF21 Antisense RNA 1 (IGSF21-AS1) is a long non-coding RNA transcribed from the antisense strand of the IGSF21 gene. Unlike IGSF21, which is a protein-coding gene involved in synaptic organization and neuronal signaling, IGSF21-AS1 does not encode a protein and its functions remain uncharacterized in the literature and major databases. As a long non-coding RNA, it may play regulatory roles in gene expression, but specific functions, disease implications, or therapeutic relevance are currently unknown[5]. Note: The search results and authoritative databases do not describe IGSF21-AS1 as a receptor, enzyme, transporter, transcription factor, or a druggable therapeutic target. If your intention is to gather information about the protein-coding gene IGSF21, refer specifically to "Immunoglobulin superfamily member 21 (IGSF21)", as this represents a distinct synaptic organizer protein involved in neuronal inhibition[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IGSF21 Antisense RNA 1 (IGSF21-AS1).